FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
PALO ALTO, Calif., Aug. 09, 2017 -- Medable Inc., the leading application and analytics platform for healthcare, today announced Tyler Pugsley has joined the company as Vice President of Life Sciences. Pugsley was the Director of Business Development for IBM Watson Health.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/64618bed-5bf5-4b24-b4e0-3961496ec3b8
“Medable is leading a new era in clinical research, in which technology enables clinical trials to be taken directly to patients, anytime, anywhere,” said Dr. Michelle Longmire, Medable CEO. “We are excited that Tyler has joined us in our mission to transform the life sciences industry. With our technology and Tyler’s industry experience, we will usher in a new era marked by globally scaled trial participation and better and more true to life data.”
Pugsley comes with a strong understanding of clinical trials and healthcare analytics, having spent the last two years with IBM Watson where he was instrumental in acquiring new pharma, biotech and Contract Resource Organization (CRO) partners.
“Medable has a truly innovative team and technology which is set to disrupt the $30 billion clinical trial outsourcing market,” said Pugsley. “For years the clinical trials industry has been saddled by legacy technology and workflow inefficiencies.
“Medable’s industry leading platform puts patients first and enables innovation at all levels of clinical trials allowing more efficient real world data collection, monitoring and analysis,” said Pugsley. “As a team, we are passionate about bringing greater value to patients and more effective therapeutics to market.”
ABOUT MEDABLE
Privately-held Palo Alto, California-based Medable provides a comprehensive, secure HIPAA-compliant cloud-based platform purpose-built for healthcare. Medable’s Axon is a “no coding required” solution enabling researchers to deliver smartphone clinical studies on a secure, HIPAA compliant technology stack. Medable’s Synapse is a clinical care app solution for providers and patients. Medable’s Cortex is the fastest way for developers to create scalable, EHR interoperable, HIPAA compliant applications. Medable’s Cerebrum is the first cloud-based machine learning solution created specifically for healthcare apps. For more information visit: www.medable.com
Follow Medable on Twitter: @Medablelinc
The photo is also available via AP PhotoExpress.
Gary Poole, PR Director [email protected]
